NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema
A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema

NCT02699450

CompletedPhase 2

Sponsor: Hoffmann-La Roche

Conditions: Diabetic Macular Edema

Interventions: Faricimab, Ranibizumab

Countries: United States

This is a multiple-center, multiple-dose, randomized, active comparator-controlled, double-masked, three parallel group, 36-week study in participants with center-involving diabetic macular edema (DME). Only one eye will be selected as the study eye. Where both eyes meet all eligibility criteria, the eye with the worse best corrected visual acuity (BCVA) will be defined as the study eye. The study will consist of a treatment period (20 weeks) and an observational period (up to 16 weeks). Treatment naive participants will be randomized in a 1:1:1 ratio to one of the Arms A, B and C, respectively. Participants previously treated with intravitreal (IVT) anti-vascular endothelial growth factor (VEGF) will be randomized in a 1:1 ratio to Arms A and C.

Eligibility overview

Sex: ALL

Age: 18 Years to

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Macular edema associated with diabetic retinopathy
* Decreased visual acuity attributable primarily to DME
* Diagnosis of diabetes mellitus

Exclusion Criteria:

* High risk proliferative diabetic retinopathy
* Cataract surgery within 3 months of Baseline, or any other previous intraocular surgery
* Uncontrolled glaucoma
* Current or history of ocular disease in the study eye other than DME
* Major illness or major surgical procedure within 1 month prior to Day 1
* Uncontrolled blood pressure
* Glycosylated hemoglobin (HbA1c) greater than (\>) 12 percent (%) at screening
* Untreated diabetes mellitus or initiation of oral anti-diabetic medication or insulin within 4 months prior to Day 1
Locations (60)
  • Phoenix, Arizona, United States
  • Phoenix, Arizona, United States
  • Phoenix, Arizona, United States
  • Tucson, Arizona, United States
  • Fullerton, California, United States
  • Inglewood, California, United States
  • Mountain View, California, United States
  • Oceanside, California, United States
  • Palm Desert, California, United States
  • Poway, California, United States
  • Sacramento, California, United States
  • Santa Barbara, California, United States
  • Walnut Creek, California, United States
  • Colorado Springs, Colorado, United States
  • Deerfield Beach, Florida, United States
  • Fort Myers, Florida, United States
  • Melbourne, Florida, United States
  • Pensacola, Florida, United States
  • St. Petersburg, Florida, United States
  • Tallahassee, Florida, United States
  • Augusta, Georgia, United States
  • Marietta, Georgia, United States
  • Chicago, Illinois, United States
  • Oak Forest, Illinois, United States
  • Oak Park, Illinois, United States
  • Indianapolis, Indiana, United States
  • West Des Moines, Iowa, United States
  • Lexington, Kentucky, United States
  • Paducah, Kentucky, United States
  • Baltimore, Maryland, United States
  • + 30 more on CT.gov